Injection site reactions such as redness, itching, or mild discomfort occur in some patients
Bottom right : The resulting clinical manifestations include unexplained increases in end-tidal CO, masseter muscle spasm or generalized muscle rigidity, tachycardia, and rapidly rising core body temperature, which together characterize the malignant hyperthermia crisis
That said, GLP-1 medications arent recommended during pregnancy
Cases, S
Despite wide dose ranges tested (6 g/kg to 20 mg/kg), multiple administration routes (intramuscular, intraperitoneal, intravenous, oral), and varied dosing frequencies across numerous animal models, no acute lethal dose has been identified
Patients seeking GLP-1 therapy should consult their healthcare provider about FDA-approved injectable or oral formulations and proper administration techniques for those products